Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about LEVODOPA: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet. View on Wiki →
No AI portrait yet
| Name | LEVODOPA |
| Key Genes/Proteins | AKT, AMPK, BDNF, COMT, DDC, DRD2 |
| Related Diseases | ALS, AMYOTROPHIC LATERAL SCLEROSIS, ATAXIA, DOPAMINE, FRONTOTEMPORAL DEMENTIA |
Knowledge base pages for this entity
graph TD
LEVODOPA["LEVODOPA"]
LEVODOPA -->|"treats"| Parkinson_s_Disease["Parkinson's Disease"]
LEVODOPA -->|"causes"| Adverse_Drug_Reactions["Adverse Drug Reactions"]
LEVODOPA -->|"treats"| Parkinson_s_disease["Parkinson's disease"]
LEVODOPA -->|"converts_to"| dopamine["dopamine"]
LEVODOPA -->|"causes"| dyskinesias["dyskinesias"]
LEVODOPA -->|"activates"| NEURON["NEURON"]
DOPAMINERGIC_NEURONS["DOPAMINERGIC NEURONS"] -->|"activates"| LEVODOPA
CORTEX["CORTEX"] -->|"regulates"| LEVODOPA
FRONTOTEMPORAL_DEMENTIA["FRONTOTEMPORAL DEMENTIA"] -->|"causes"| LEVODOPA
ALS["ALS"] -->|"causes"| LEVODOPA| Target | Relation | Type | Str |
|---|---|---|---|
| Parkinson'S Disease | treats | disease | 0.95 |
| Parkinson's Disease | treats | disease | 0.95 |
| Levodopa-Induced Dyskinesia | causes | phenotype | 0.95 |
| Parkinson Disease | treats | disease | 0.95 |
| Motor Fluctuations | causes | phenotype | 0.90 |
| Parkinsonism | treats | phenotype | 0.90 |
| Levodopa Response | associated_with | phenotype | 0.90 |
| Adverse Drug Reactions | causes | phenotype | 0.85 |
| SLC6A3 | targets | gene | 0.85 |
| Levodopa-induced dyskinesia | causes | phenotype | 0.85 |
| Motor fluctuations | causes | phenotype | 0.85 |
| AADC | targets | gene | 0.80 |
| DRD2 | targets | gene | 0.80 |
| PARKINSON'S DISEASE | treats | disease | 0.80 |
| TH | associated_with | gene | 0.70 |
| AADC | associated_with | gene | 0.70 |
| dyskinesias | causes | disease | 0.70 |
| TH | targets | gene | 0.70 |
| TH | releases | gene | 0.70 |
| AADC | releases | gene | 0.70 |
| COMT | targets | gene | 0.70 |
| dopamine | converts_to | protein | 0.70 |
| Parkinson's disease | associated_with | disease | 0.70 |
| Parkinson's disease | treats | disease | 0.70 |
| COMT | activates | gene | 0.70 |
| PARKINSON'S DISEASE | activates | disease | 0.70 |
| PARKINSON'S DISEASE | inhibits | disease | 0.65 |
| PARKINSON | treats | disease | 0.65 |
| NEURON | promotes | cell_type | 0.65 |
| NEURONS | promotes | cell_type | 0.65 |
| PARKIN | treats | gene | 0.65 |
| STING | targets | gene | 0.65 |
| GBA | exacerbates | gene | 0.65 |
| oxidative stress response | modulates | pathway | 0.65 |
| GDNF | targets | gene | 0.60 |
| MTHFR | targets | gene | 0.60 |
| PLK2 | targets | gene | 0.60 |
| MAO | targets | gene | 0.60 |
| dopamine receptor | treats | receptor | 0.60 |
| TH | transported_by | gene | 0.60 |
| AADC | transported_by | gene | 0.60 |
| CDNF | targets | gene | 0.60 |
| NOX2 | targets | gene | 0.60 |
| PINK1 | targets | gene | 0.60 |
| ANKK1 | targets | gene | 0.60 |
| DJ1 | targets | gene | 0.60 |
| ALS | treats | disease | 0.60 |
| frontotemporal dementia | treats | disease | 0.60 |
| neuroinflammation | treats | disease | 0.60 |
| GAPDH | targets | gene | 0.60 |
| Source | Relation | Type | Str |
|---|---|---|---|
| PARKINSON | associated_with | disease | 0.70 |
| ATAXIA | mediates | disease | 0.65 |
| TH | activates | gene | 0.65 |
| TH | treats | gene | 0.65 |
| DOPAMINE | activates | phenotype | 0.65 |
| DRD2 | associated_with | gene | 0.65 |
| PARKINSON'S DISEASE | associated_with | disease | 0.50 |
| PARKINSON | associated_with | disease | 0.50 |
| NEURODEGENERATION | associated_with | phenotype | 0.50 |
| SEROTONIN | associated_with | phenotype | 0.50 |
| SEMAGLUTIDE | associated_with | drug | 0.45 |
| DOPAMINE | associated_with | phenotype | 0.45 |
| ALS | associated_with | disease | 0.45 |
| SPINOCEREBELLAR ATAXIA | associated_with | disease | 0.45 |
| AMYOTROPHIC LATERAL SCLEROSIS | associated_with | disease | 0.45 |
| UBIQUITIN | associated_with | protein | 0.45 |
| CARBIDOPA | associated_with | drug | 0.45 |
| FRONTOTEMPORAL DEMENTIA | causes | disease | 0.35 |
| ALS | causes | disease | 0.35 |
| CORTEX | regulates | brain_region | 0.35 |
| DOPAMINERGIC NEURONS | activates | cell_type | 0.35 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity